| 2015 | 2014 | 2013 | ||||
|---|---|---|---|---|---|---|
| Revenue | 315,1 k € | -90.5% | 3,3 M € | +40.6% | 2,4 M € | |
| Gross margin | 992,4 k € | +54.2% | 643,7 k € | +52.5% | 422,1 k € | |
| EBITDA | 729,9 k € | +22.5% | 596,0 k € | +41.5% | 421,3 k € | |
| Operating profit | 101,3 k € | -27.9% | 140,5 k € | +11.4% | 126,2 k € | |
| Profit/loss | 7,5 k € | -60.9% | 19,2 k € | -48.9% | 37,6 k € | |
| Equity | 696,7 k € | +1.1% | 689,2 k € | +2.9% | 670,0 k € | |
| Total assets | 10,0 M € | +80.0% | 5,5 M € | +11.4% | 5,0 M € | |
| Cash | 104,6 k € | -20.1% | 130,9 k € | +430.8% | 24,7 k € | |
| Debts | 9,3 M € | +91.2% | 4,8 M € | +13.9% | 4,3 M € | |
| Staff | 6,3 | 1 | — | |||
Source: Belgian Official Gazette
Public limited company · Pepingen · incorporated on 28/11/2012 · 6,3 ETP
Company — Opening of bankruptcy.
Public limited company profitable and well capitalised. Cash position declining (-20.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Bio-Cen Technology is a Public limited company incorporated in 2012. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Pepingen. It employs on average 6,3 ETP workers (FTE).